HealthEconomics.Com’s tweets have become an essential way for the global HEOR audience of more than 20,000 individuals to be more deeply engaged with industry meeting content and to network with other meeting attendees...
Ponte Vedra Beach, FL (PRWEB) May 28, 2013
HealthEconomics.Com, the global authority on healthcare value and market access, for the third time this year, was recognized by industry leaders through Symplur.com as a top industry meeting influencer, this time based on tweets during the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International meeting, held May 18 through 22 at the Sheraton New Orleans, New Orleans, LA. The title of Top Influencer is awarded based on the volume of tweets containing the hashtag for the ISPOR Meeting (#ISPORNewOrleans), and analysis of each tweet’s reach. Previously, HealthEconomics.Com has been recognized as Top Influencer for the Academy of Managed Care Pharmacy Annual Meeting and Expo, and the National Association of Specialty Pharmacy meeting, both held in San Diego, California in April 2013.
Tweets from HealthEconomics.Com (@www_healthecon) during the Annual International ISPOR meeting provided live updates to their world-wide community of followers within HEOR (Health Economics and Outcomes Research) on a variety of policy and research issues, including a new evidence evaluation matrix tool, multi-criteria decision analysis methods, and cost-benefit techniques, among others. HealthEconomics.Com sent out more than 150 tweets from the ISPOR meeting over 3 days. The tweets covered live podium presentations, symposia, poster presentations, and exhibit floor activities. HealthEconomics.Com’s tweets have become an essential way for the global HEOR audience of more than 20,000 individuals to be more deeply engaged with industry meeting content and to network with other meeting attendees including researchers, policy-makers, providers, and service organizations.
The International Society for Pharmacoeconomics and Outcomes Research (http://www.ispor.org) promotes the science of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes) and facilitates the translation of this research into useful information for healthcare decision-makers to increase the efficiency, effectiveness, and fairness of health care to improve health. Founded in 1995, ISPOR is a non-profit public organization for educational and scientific purposes.
About HealthEconomics.Com (http://www.healtheconomics.com):
A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.
News Media interested in receiving the most current information on healthcare value and market access may access for free any resources and news on HealthEconomics.Com by visiting the website or by subscribing to the weekly HealthEconomics.Com Newsletter.